Global Surface Disinfectant Market will become worth US$1.77 bn by 2024, Says TMR
Nov 08, 2017 11:47 am UTC| Business
ALBANY, New York, Nov. 08, 2017 -- The global surface disinfectant market is foreseen to witness a significant growth in coming years. The growth in education standards and rising disposable incomes are estimated to be...
Flame Resistant Fabrics Market to be worth US$ 6.56 Bn by 2024 - Transparency Market Research
Nov 08, 2017 11:34 am UTC| Business
ALBANY, New York, Nov. 08, 2017 -- The competition among the players operating in the global market for flame resistant fabrics is anticipated to intensify over the years ahead owing to the unique product categories...
Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock
Nov 08, 2017 11:30 am UTC| Business
SAN DIEGO, Nov. 08, 2017 -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock equivalents at a price to the public of...
Hydrogenics to Present at Upcoming Investor Events
Nov 08, 2017 11:30 am UTC| Business
MISSISSAUGA, Ontario, Nov. 08, 2017 -- Hydrogenics Corporation (NASDAQ:HYGS) (TSX:HYG) (“Hydrogenics” or “the Company”), a leading developer and manufacturer of hydrogen generation and hydrogen-based power modules,...
EMC Insurance Group Inc. Reports 2017 Third Quarter and Nine Month Results
Nov 08, 2017 11:30 am UTC| Business
Third Quarter Ended September 30, 2017Net Income Per Share – $0.03Non-GAAP Operating Income Per Share* – $0.05Net Realized Investment Losses Per Share – $0.02Catastrophe and Storm Losses Per Share – $0.90GAAP Combined...
STEP Energy Services Ltd. Reports Record Third Quarter 2017 Financial and Operating Results
Nov 08, 2017 11:30 am UTC| Business
CALGARY, Alberta, Nov. 08, 2017 -- STEP Energy Services Ltd. (TSX:STEP) (the “Company” or “STEP”) today announces record financial and operating results for the three and nine months ended September 30, 2017. The...
Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt Disease
Nov 08, 2017 11:30 am UTC| Business
Fourth Gene Therapy Program Targets the Most Common Inherited Juvenile Macular Dystrophy LEXINGTON, Mass. and LONDON, Nov. 08, 2017 -- Nightstar Therapeutics (NASDAQ:NITE), a clinical-stage gene therapy company...